Correlation Between Edgewise Therapeutics and Estrella Immunopharma
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Estrella Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Estrella Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Estrella Immunopharma, you can compare the effects of market volatilities on Edgewise Therapeutics and Estrella Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Estrella Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Estrella Immunopharma.
Diversification Opportunities for Edgewise Therapeutics and Estrella Immunopharma
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Edgewise and Estrella is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Estrella Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Estrella Immunopharma and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Estrella Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Estrella Immunopharma has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Estrella Immunopharma go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Estrella Immunopharma
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Estrella Immunopharma. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 2.1 times less risky than Estrella Immunopharma. The stock trades about -0.05 of its potential returns per unit of risk. The Estrella Immunopharma is currently generating about 0.44 of returns per unit of risk over similar time horizon. If you would invest 73.00 in Estrella Immunopharma on September 2, 2024 and sell it today you would earn a total of 41.00 from holding Estrella Immunopharma or generate 56.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Estrella Immunopharma
Performance |
| Timeline |
| Edgewise Therapeutics |
| Estrella Immunopharma |
Edgewise Therapeutics and Estrella Immunopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Estrella Immunopharma
The main advantage of trading using opposite Edgewise Therapeutics and Estrella Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Estrella Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Estrella Immunopharma will offset losses from the drop in Estrella Immunopharma's long position.| Edgewise Therapeutics vs. Tff Pharmaceuticals | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Inhibrx | Edgewise Therapeutics vs. Enliven Therapeutics |
| Estrella Immunopharma vs. Ambev SA ADR | Estrella Immunopharma vs. Boston Beer | Estrella Immunopharma vs. National Beverage Corp | Estrella Immunopharma vs. Anheuser Busch Inbev |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |